Britain Moving Too Fast on 3-Parent Children
By Editorial,
Los Angeles Times
| 03. 11. 2015
Untitled Document
A procedure newly approved in Britain allows babies to be conceived with DNA from three parents — a mix of DNA that would determine the child's characteristics and become part of the gene pool in future generations. Last year, a U.S. Food and Drug Administration advisory panel wisely decided that this procedure, designed to overcome the devastating effects of mitochondrial disease, wasn't ready for human trials, much less therapeutic use. With its premature approval, Britain has opened the way for three-parent children around the world, because anyone with enough money can travel there for the procedure.
Mitochondria are the specialized compartments within cells that are responsible for creating most of the energy needed by the body. But when a mother's mitochondria are faulty, the resulting disorder can be disabling or fatal to her offspring. Children born with mitochondrial disorder might lose muscle control, suffer muscle weakness and pain, have difficulty breathing and be beset by heart and liver problems.
Researchers hope to overcome this by removing the nucleus from the egg of a woman who has the disorder...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...